Résumé
Les effets secondaires cardiovasculaires des médicaments anticholinestérasiques sont une préoccupation fréquente pour les gériatres traitant des pathologies cognitives.
This is a preview of subscription content, log in via an institution.
Preview
Unable to display preview. Download preview PDF.
Références
Ferreri F, Agbokou C, Gauthier S (2007) Mise au point: effets cardiovasculaires des inhibiteurs de la cholinesterase dans la maladie d’Alzheimer. Rev Neurol 163: 968–74
Tavassoli N, Sommet A, Lapeyre-Mestre M., et al. (2007) Drugs interactions with cholinesterase inhibitors. Drug Safety 30(11): 1063–71
Bordier P, Lanusse S, Garrigue S, et al. (2005) Cause of syncope in patients with Alzheimer disease treated with Donapezil. Drugs Aging 22: 687–94
World Health Organisation (2004) Cholinesterase inhibitors and cardiac arythmias. WHO Drug Information — Safety and Efficacy issues 18: 273–4
Brembillat-Peyrot B, Regent MC, Hanesse B. et al. (2004) Troubles de la conduction auriculo-ventriculaires paroxystiques liés à la prise d’un anticholinestérasique. Arch Mal Coeur Vaiss 97: 1265–7
Hernandez RK, Farwell W., Cantor MD, Lawler EV (2009) Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the Veterans Affairs New England Healthcare System. J Am Geriatr Soc 57: 1997–2003
Pratt RD, Perdomo CA, Surick IW (2002) Donepezil: tolerability and safety in Alzheimer disease. Int J Clin Pract 56710–7
Ballard C, Lane R, Barone P. et al. (2006) Cardiac safety of rivastigmine in Lewy body and Parkinson disease dementia. Int J Clin Pract 60: 639–45
Park-Willie LY, Mamdani MM, Li P, et al. (2009) Cholinesterase inhibitors and hospitalization for bradycardia: a population based study. PLOS medicine 6(9): 1–9
Gill SS, Anderson GM, Fischer HD, et al. (2009) Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors. Arch Intern Med 169: 867–73
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2013 Springer-Verlag Paris
About this chapter
Cite this chapter
Fontan, B., Toulza, O. (2013). Complications cardiovasculaires des inhibiteurs des cholinestérases. In: Traité sur la maladie d’Alzheimer. Springer, Paris. https://doi.org/10.1007/978-2-8178-0443-9_16
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0443-9_16
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0442-2
Online ISBN: 978-2-8178-0443-9